Pharma & Healthcare
Global Prostacyclin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 12, 25
- ID: 307358
- Pages: 122
- Figures: 133
- Views: 1
In 2024, the global market size of Prostacyclin was estimated to be worth US$ 2712 million and is forecast to reach approximately US$ 4355 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.
North America is the largest market, with a share about 80%, followed by Europe and Japan, have a share about 15 percent.
In terms of product, Beraprost Sodium is the largest segment, with a share over 50%. And in terms of application, the largest application is For Oral, followed by For Injection, For Inhalation.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prostacyclin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostacyclin.
The Prostacyclin market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostacyclin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostacyclin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
Segment by Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Segment by Application
For Injection
For Oral
For Inhalation
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Prostacyclin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Prostacyclin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostacyclin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.
North America is the largest market, with a share about 80%, followed by Europe and Japan, have a share about 15 percent.
In terms of product, Beraprost Sodium is the largest segment, with a share over 50%. And in terms of application, the largest application is For Oral, followed by For Injection, For Inhalation.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prostacyclin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostacyclin.
The Prostacyclin market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostacyclin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostacyclin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
Segment by Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Segment by Application
For Injection
For Oral
For Inhalation
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Prostacyclin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Prostacyclin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostacyclin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Prostacyclin Product Introduction
1.2 Market by Type
1.2.1 Global Prostacyclin Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Epoprostenol Sodium
1.2.3 Treprostinil
1.2.4 Iloprost
1.2.5 Beraprost Sodium
1.3 Market by Application
1.3.1 Global Prostacyclin Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 For Injection
1.3.3 For Oral
1.3.4 For Inhalation
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prostacyclin Market Size Estimates and Forecasts
2.1.1 Global Prostacyclin Revenue 2020-2031
2.1.2 Global Prostacyclin Sales 2020-2031
2.2 Prostacyclin Market Size by Region: 2024 Versus 2031
2.3 Prostacyclin Sales by Region (2020-2031)
2.3.1 Global Prostacyclin Sales by Region: 2020-2025
2.3.2 Global Prostacyclin Sales Forecast by Region (2026-2031)
2.3.3 Global Prostacyclin Sales Market Share by Region (2020-2031)
2.4 Prostacyclin Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Prostacyclin Revenue by Region: 2020-2025
2.4.2 Global Prostacyclin Revenue Forecast by Region (2026-2031)
2.4.3 Global Prostacyclin Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Prostacyclin Sales by Type (2020-2031)
3.1.1.1 Global Prostacyclin Sales Volume by Type (2020-2031)
3.1.1.2 Global Prostacyclin Sales Market Share by Type (2020-2031)
3.1.2 Global Prostacyclin Revenue by Type (2020-2031)
3.1.2.1 Global Prostacyclin Revenue by Type (2020-2031)
3.1.2.2 Global Prostacyclin Revenue Market Share by Type (2020-2031)
3.1.3 Prostacyclin Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Prostacyclin Sales by Application (2020-2031)
3.2.1.1 Global Prostacyclin Sales Volume by Application (2020-2031)
3.2.1.2 Global Prostacyclin Sales Market Share by Application (2020-2031)
3.2.2 Global Prostacyclin Revenue by Application (2020-2031)
3.2.2.1 Global Prostacyclin Revenue by Application (2020-2031)
3.2.2.2 Global Prostacyclin Revenue Market Share by Application (2020-2031)
3.2.3 Prostacyclin Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Epoprostenol Sodium of Prostacyclin Revenue Market Share by Application
3.3.2 Treprostinil of Prostacyclin Revenue Market Share by Application
3.3.3 Iloprost of Prostacyclin Revenue Market Share by Application
3.3.4 Beraprost Sodium of Prostacyclin Revenue Market Share by Application
4 Global Prostacyclin by Manufacturers
4.1 Global Top Prostacyclin Manufacturers by Sales (2020-2025)
4.1.1 Global Prostacyclin Sales by Manufacturer (2020-2025)
4.1.2 Global Prostacyclin Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Prostacyclin Manufacturers by Revenue (2020-2025)
4.2.1 Global Prostacyclin Revenue by Manufacturer (2020-2025)
4.2.2 Global Prostacyclin Revenue Share by Manufacturer (2020-2025)
4.3 Global Prostacyclin Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Prostacyclin Manufacturers Covered: Ranking by Revenue
4.4.2 Global Prostacyclin Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Prostacyclin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Prostacyclin Manufacturing Base Distribution, Product Type
4.5.1 Prostacyclin Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Prostacyclin Market
4.5.3 Manufacturers Prostacyclin Product Type and Application
4.5.4 Epoprostenol Sodium Market Sales of Prostacyclin by Manufacturer
4.5.5 Treprostinil Market Sales of Prostacyclin by Manufacturer
4.5.6 Iloprost Market Sales of Prostacyclin by Manufacturer
4.5.7 Beraprost Sodium Market Sales of Prostacyclin by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 United Therapeutics
5.1.1 United Therapeutics Company Information
5.1.2 United Therapeutics Description, Business Overview
5.1.3 United Therapeutics Prostacyclin Products Offered
5.1.4 United Therapeutics Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.1.5 United Therapeutics Prostacyclin Sales by Product in 2024
5.1.6 United Therapeutics Prostacyclin Sales by Application in 2024
5.1.7 United Therapeutics Prostacyclin Sales by Geographic Area in 2024
5.1.8 United Therapeutics Recent Developments
5.2 Actelion (J & J)
5.2.1 Actelion (J & J) Company Information
5.2.2 Actelion (J & J) Description, Business Overview
5.2.3 Actelion (J & J) Prostacyclin Products Offered
5.2.4 Actelion (J & J) Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Actelion (J & J) Prostacyclin Sales by Product in 2024
5.2.6 Actelion (J & J) Prostacyclin Sales by Application in 2024
5.2.7 Actelion (J & J) Prostacyclin Sales by Geographic Area in 2024
5.2.8 Actelion (J & J) Recent Developments
5.3 GSK
5.3.1 GSK Company Information
5.3.2 GSK Description, Business Overview
5.3.3 GSK Prostacyclin Products Offered
5.3.4 GSK Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.3.5 GSK Prostacyclin Sales by Product in 2024
5.3.6 GSK Prostacyclin Sales by Application in 2024
5.3.7 GSK Prostacyclin Sales by Geographic Area in 2024
5.3.8 GSK Recent Developments
5.4 Teva
5.4.1 Teva Company Information
5.4.2 Teva Description, Business Overview
5.4.3 Teva Prostacyclin Products Offered
5.4.4 Teva Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Teva Prostacyclin Sales by Product in 2024
5.4.6 Teva Prostacyclin Sales by Application in 2024
5.4.7 Teva Prostacyclin Sales by Geographic Area in 2024
5.4.8 Teva Recent Developments
5.5 Toray
5.5.1 Toray Company Information
5.5.2 Toray Description, Business Overview
5.5.3 Toray Prostacyclin Products Offered
5.5.4 Toray Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Toray Prostacyclin Sales by Product in 2024
5.5.6 Toray Prostacyclin Sales by Application in 2024
5.5.7 Toray Prostacyclin Sales by Geographic Area in 2024
5.5.8 Toray Recent Developments
5.6 Tide Pharma
5.6.1 Tide Pharma Company Information
5.6.2 Tide Pharma Description, Business Overview
5.6.3 Tide Pharma Prostacyclin Products Offered
5.6.4 Tide Pharma Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Tide Pharma Prostacyclin Sales by Product in 2024
5.6.6 Tide Pharma Prostacyclin Sales by Application in 2024
5.6.7 Tide Pharma Prostacyclin Sales by Geographic Area in 2024
5.6.8 Tide Pharma Recent Developments
5.7 Bayer AG
5.7.1 Bayer AG Company Information
5.7.2 Bayer AG Description, Business Overview
5.7.3 Bayer AG Prostacyclin Products Offered
5.7.4 Bayer AG Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Bayer AG Prostacyclin Sales by Product in 2024
5.7.6 Bayer AG Prostacyclin Sales by Application in 2024
5.7.7 Bayer AG Prostacyclin Sales by Geographic Area in 2024
5.7.8 Bayer AG Recent Developments
6 North America
6.1 North America Prostacyclin Market Size YoY Growth 2020-2031
6.2 North America Prostacyclin Market Facts & Figures by Country
6.2.1 North America Prostacyclin Sales by Country (2020-2031)
6.2.2 North America Prostacyclin Revenue by Country (2020-2031)
6.3 North America Prostacyclin Sales by Type (2020-2025)
6.4 North America Prostacyclin Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Prostacyclin Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Prostacyclin Market Facts & Figures by Region
7.2.1 Asia-Pacific Prostacyclin Sales by Region (2020-2031)
7.2.2 Asia-Pacific Prostacyclin Revenue by Region (2020-2031)
7.3 Asia-Pacific Prostacyclin Sales by Type (2020-2025)
7.4 Asia-Pacific Prostacyclin Sales by Application (2020-2025)
8 Europe
8.1 Europe Prostacyclin Market Size YoY Growth 2020-2031
8.2 Europe Prostacyclin Market Facts & Figures by Country
8.2.1 Europe Prostacyclin Sales by Country (2020-2031)
8.2.2 Europe Prostacyclin Revenue by Country (2020-2031)
8.3 Europe Prostacyclin Sales by Type (2020-2025)
8.4 Europe Prostacyclin Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Prostacyclin Market Size YoY Growth 2020-2031
9.2 Latin America Prostacyclin Market Facts & Figures by Country
9.2.1 Latin America Prostacyclin Sales by Country (2020-2031)
9.2.2 Latin America Prostacyclin Revenue by Country (2020-2031)
9.3 Latin America Prostacyclin Sales by Type (2020-2025)
9.4 Latin America Prostacyclin Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Prostacyclin Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Prostacyclin Market Facts & Figures by Country
10.2.1 Middle East and Africa Prostacyclin Sales by Country (2020-2031)
10.2.2 Middle East and Africa Prostacyclin Revenue by Country (2020-2031)
10.3 Middle East and Africa Prostacyclin Sales by Type (2020-2025)
10.4 Middle East and Africa Prostacyclin Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Prostacyclin Supply Chain Analysis
11.2 Prostacyclin Key Raw Materials and Upstream Suppliers
11.3 Prostacyclin Clients Analysis
11.4 Prostacyclin Sales Channel and Sales Model Analysis
11.4.1 Prostacyclin Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Prostacyclin Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Prostacyclin Distributors
12 Prostacyclin Market Dynamics
12.1 Prostacyclin Industry Trends
12.2 Prostacyclin Market Drivers
12.3 Prostacyclin Market Challenges
12.4 Prostacyclin Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Prostacyclin Product Introduction
1.2 Market by Type
1.2.1 Global Prostacyclin Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Epoprostenol Sodium
1.2.3 Treprostinil
1.2.4 Iloprost
1.2.5 Beraprost Sodium
1.3 Market by Application
1.3.1 Global Prostacyclin Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 For Injection
1.3.3 For Oral
1.3.4 For Inhalation
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prostacyclin Market Size Estimates and Forecasts
2.1.1 Global Prostacyclin Revenue 2020-2031
2.1.2 Global Prostacyclin Sales 2020-2031
2.2 Prostacyclin Market Size by Region: 2024 Versus 2031
2.3 Prostacyclin Sales by Region (2020-2031)
2.3.1 Global Prostacyclin Sales by Region: 2020-2025
2.3.2 Global Prostacyclin Sales Forecast by Region (2026-2031)
2.3.3 Global Prostacyclin Sales Market Share by Region (2020-2031)
2.4 Prostacyclin Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Prostacyclin Revenue by Region: 2020-2025
2.4.2 Global Prostacyclin Revenue Forecast by Region (2026-2031)
2.4.3 Global Prostacyclin Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Prostacyclin Sales by Type (2020-2031)
3.1.1.1 Global Prostacyclin Sales Volume by Type (2020-2031)
3.1.1.2 Global Prostacyclin Sales Market Share by Type (2020-2031)
3.1.2 Global Prostacyclin Revenue by Type (2020-2031)
3.1.2.1 Global Prostacyclin Revenue by Type (2020-2031)
3.1.2.2 Global Prostacyclin Revenue Market Share by Type (2020-2031)
3.1.3 Prostacyclin Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Prostacyclin Sales by Application (2020-2031)
3.2.1.1 Global Prostacyclin Sales Volume by Application (2020-2031)
3.2.1.2 Global Prostacyclin Sales Market Share by Application (2020-2031)
3.2.2 Global Prostacyclin Revenue by Application (2020-2031)
3.2.2.1 Global Prostacyclin Revenue by Application (2020-2031)
3.2.2.2 Global Prostacyclin Revenue Market Share by Application (2020-2031)
3.2.3 Prostacyclin Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Epoprostenol Sodium of Prostacyclin Revenue Market Share by Application
3.3.2 Treprostinil of Prostacyclin Revenue Market Share by Application
3.3.3 Iloprost of Prostacyclin Revenue Market Share by Application
3.3.4 Beraprost Sodium of Prostacyclin Revenue Market Share by Application
4 Global Prostacyclin by Manufacturers
4.1 Global Top Prostacyclin Manufacturers by Sales (2020-2025)
4.1.1 Global Prostacyclin Sales by Manufacturer (2020-2025)
4.1.2 Global Prostacyclin Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Prostacyclin Manufacturers by Revenue (2020-2025)
4.2.1 Global Prostacyclin Revenue by Manufacturer (2020-2025)
4.2.2 Global Prostacyclin Revenue Share by Manufacturer (2020-2025)
4.3 Global Prostacyclin Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Prostacyclin Manufacturers Covered: Ranking by Revenue
4.4.2 Global Prostacyclin Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Prostacyclin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Prostacyclin Manufacturing Base Distribution, Product Type
4.5.1 Prostacyclin Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Prostacyclin Market
4.5.3 Manufacturers Prostacyclin Product Type and Application
4.5.4 Epoprostenol Sodium Market Sales of Prostacyclin by Manufacturer
4.5.5 Treprostinil Market Sales of Prostacyclin by Manufacturer
4.5.6 Iloprost Market Sales of Prostacyclin by Manufacturer
4.5.7 Beraprost Sodium Market Sales of Prostacyclin by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 United Therapeutics
5.1.1 United Therapeutics Company Information
5.1.2 United Therapeutics Description, Business Overview
5.1.3 United Therapeutics Prostacyclin Products Offered
5.1.4 United Therapeutics Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.1.5 United Therapeutics Prostacyclin Sales by Product in 2024
5.1.6 United Therapeutics Prostacyclin Sales by Application in 2024
5.1.7 United Therapeutics Prostacyclin Sales by Geographic Area in 2024
5.1.8 United Therapeutics Recent Developments
5.2 Actelion (J & J)
5.2.1 Actelion (J & J) Company Information
5.2.2 Actelion (J & J) Description, Business Overview
5.2.3 Actelion (J & J) Prostacyclin Products Offered
5.2.4 Actelion (J & J) Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Actelion (J & J) Prostacyclin Sales by Product in 2024
5.2.6 Actelion (J & J) Prostacyclin Sales by Application in 2024
5.2.7 Actelion (J & J) Prostacyclin Sales by Geographic Area in 2024
5.2.8 Actelion (J & J) Recent Developments
5.3 GSK
5.3.1 GSK Company Information
5.3.2 GSK Description, Business Overview
5.3.3 GSK Prostacyclin Products Offered
5.3.4 GSK Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.3.5 GSK Prostacyclin Sales by Product in 2024
5.3.6 GSK Prostacyclin Sales by Application in 2024
5.3.7 GSK Prostacyclin Sales by Geographic Area in 2024
5.3.8 GSK Recent Developments
5.4 Teva
5.4.1 Teva Company Information
5.4.2 Teva Description, Business Overview
5.4.3 Teva Prostacyclin Products Offered
5.4.4 Teva Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Teva Prostacyclin Sales by Product in 2024
5.4.6 Teva Prostacyclin Sales by Application in 2024
5.4.7 Teva Prostacyclin Sales by Geographic Area in 2024
5.4.8 Teva Recent Developments
5.5 Toray
5.5.1 Toray Company Information
5.5.2 Toray Description, Business Overview
5.5.3 Toray Prostacyclin Products Offered
5.5.4 Toray Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Toray Prostacyclin Sales by Product in 2024
5.5.6 Toray Prostacyclin Sales by Application in 2024
5.5.7 Toray Prostacyclin Sales by Geographic Area in 2024
5.5.8 Toray Recent Developments
5.6 Tide Pharma
5.6.1 Tide Pharma Company Information
5.6.2 Tide Pharma Description, Business Overview
5.6.3 Tide Pharma Prostacyclin Products Offered
5.6.4 Tide Pharma Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Tide Pharma Prostacyclin Sales by Product in 2024
5.6.6 Tide Pharma Prostacyclin Sales by Application in 2024
5.6.7 Tide Pharma Prostacyclin Sales by Geographic Area in 2024
5.6.8 Tide Pharma Recent Developments
5.7 Bayer AG
5.7.1 Bayer AG Company Information
5.7.2 Bayer AG Description, Business Overview
5.7.3 Bayer AG Prostacyclin Products Offered
5.7.4 Bayer AG Prostacyclin Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Bayer AG Prostacyclin Sales by Product in 2024
5.7.6 Bayer AG Prostacyclin Sales by Application in 2024
5.7.7 Bayer AG Prostacyclin Sales by Geographic Area in 2024
5.7.8 Bayer AG Recent Developments
6 North America
6.1 North America Prostacyclin Market Size YoY Growth 2020-2031
6.2 North America Prostacyclin Market Facts & Figures by Country
6.2.1 North America Prostacyclin Sales by Country (2020-2031)
6.2.2 North America Prostacyclin Revenue by Country (2020-2031)
6.3 North America Prostacyclin Sales by Type (2020-2025)
6.4 North America Prostacyclin Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Prostacyclin Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Prostacyclin Market Facts & Figures by Region
7.2.1 Asia-Pacific Prostacyclin Sales by Region (2020-2031)
7.2.2 Asia-Pacific Prostacyclin Revenue by Region (2020-2031)
7.3 Asia-Pacific Prostacyclin Sales by Type (2020-2025)
7.4 Asia-Pacific Prostacyclin Sales by Application (2020-2025)
8 Europe
8.1 Europe Prostacyclin Market Size YoY Growth 2020-2031
8.2 Europe Prostacyclin Market Facts & Figures by Country
8.2.1 Europe Prostacyclin Sales by Country (2020-2031)
8.2.2 Europe Prostacyclin Revenue by Country (2020-2031)
8.3 Europe Prostacyclin Sales by Type (2020-2025)
8.4 Europe Prostacyclin Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Prostacyclin Market Size YoY Growth 2020-2031
9.2 Latin America Prostacyclin Market Facts & Figures by Country
9.2.1 Latin America Prostacyclin Sales by Country (2020-2031)
9.2.2 Latin America Prostacyclin Revenue by Country (2020-2031)
9.3 Latin America Prostacyclin Sales by Type (2020-2025)
9.4 Latin America Prostacyclin Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Prostacyclin Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Prostacyclin Market Facts & Figures by Country
10.2.1 Middle East and Africa Prostacyclin Sales by Country (2020-2031)
10.2.2 Middle East and Africa Prostacyclin Revenue by Country (2020-2031)
10.3 Middle East and Africa Prostacyclin Sales by Type (2020-2025)
10.4 Middle East and Africa Prostacyclin Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Prostacyclin Supply Chain Analysis
11.2 Prostacyclin Key Raw Materials and Upstream Suppliers
11.3 Prostacyclin Clients Analysis
11.4 Prostacyclin Sales Channel and Sales Model Analysis
11.4.1 Prostacyclin Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Prostacyclin Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Prostacyclin Distributors
12 Prostacyclin Market Dynamics
12.1 Prostacyclin Industry Trends
12.2 Prostacyclin Market Drivers
12.3 Prostacyclin Market Challenges
12.4 Prostacyclin Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Prostacyclin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Prostacyclin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Prostacyclin Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Prostacyclin Sales by Region (2020-2025) & (K Unit)
Table 5. Global Prostacyclin Sales Forecast by Region (2026-2031) & (K Unit)
Table 6. Global Prostacyclin Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Prostacyclin Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Prostacyclin Sales Volume by Type (2020-2025) & (K Unit)
Table 9. Global Prostacyclin Sales Volume by Type (2026-2031) & (K Unit)
Table 10. Global Prostacyclin Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Prostacyclin Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Prostacyclin Sales Volume by Application (2020-2025) & (K Unit)
Table 13. Global Prostacyclin Sales Volume by Application (2026-2031) & (K Unit)
Table 14. Global Prostacyclin Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Prostacyclin Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Prostacyclin Sales by Manufacturer (2020-2025) & (K Unit)
Table 17. Global Prostacyclin Sales Share by Manufacturer (2020-2025)
Table 18. Prostacyclin Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Prostacyclin Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Prostacyclin Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Prostacyclin Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Prostacyclin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Prostacyclin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostacyclin as of 2024)
Table 24. Prostacyclin Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Prostacyclin Market
Table 26. Manufacturers Prostacyclin Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. United Therapeutics Company Information
Table 29. United Therapeutics Description and Business Overview
Table 30. United Therapeutics Prostacyclin Product
Table 31. United Therapeutics Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. United Therapeutics Sales Proportion of Prostacyclin by Product in 2024
Table 33. United Therapeutics Sales Proportion of Prostacyclin by Application in 2024
Table 34. United Therapeutics Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 35. United Therapeutics Recent Developments
Table 36. Actelion (J & J) Company Information
Table 37. Actelion (J & J) Description and Business Overview
Table 38. Actelion (J & J) Prostacyclin Product
Table 39. Actelion (J & J) Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Actelion (J & J) Sales Proportion of Prostacyclin by Product in 2024
Table 41. Actelion (J & J) Sales Proportion of Prostacyclin by Application in 2024
Table 42. Actelion (J & J) Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 43. Actelion (J & J) Recent Developments
Table 44. GSK Company Information
Table 45. GSK Description and Business Overview
Table 46. GSK Prostacyclin Product
Table 47. GSK Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. GSK Sales Proportion of Prostacyclin by Product in 2024
Table 49. GSK Sales Proportion of Prostacyclin by Application in 2024
Table 50. GSK Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 51. GSK Recent Developments
Table 52. Teva Company Information
Table 53. Teva Description and Business Overview
Table 54. Teva Prostacyclin Product
Table 55. Teva Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Teva Sales Proportion of Prostacyclin by Product in 2024
Table 57. Teva Sales Proportion of Prostacyclin by Application in 2024
Table 58. Teva Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 59. Teva Recent Developments
Table 60. Toray Company Information
Table 61. Toray Description and Business Overview
Table 62. Toray Prostacyclin Product
Table 63. Toray Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Toray Sales Proportion of Prostacyclin by Product in 2024
Table 65. Toray Sales Proportion of Prostacyclin by Application in 2024
Table 66. Toray Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 67. Toray Recent Developments
Table 68. Tide Pharma Company Information
Table 69. Tide Pharma Description and Business Overview
Table 70. Tide Pharma Prostacyclin Product
Table 71. Tide Pharma Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Tide Pharma Sales Proportion of Prostacyclin by Product in 2024
Table 73. Tide Pharma Sales Proportion of Prostacyclin by Application in 2024
Table 74. Tide Pharma Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 75. Tide Pharma Recent Developments
Table 76. Bayer AG Company Information
Table 77. Bayer AG Description and Business Overview
Table 78. Bayer AG Prostacyclin Product
Table 79. Bayer AG Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Bayer AG Sales Proportion of Prostacyclin by Product in 2024
Table 81. Bayer AG Sales Proportion of Prostacyclin by Application in 2024
Table 82. Bayer AG Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 83. Bayer AG Recent Developments
Table 84. North America Prostacyclin Sales by Country (2020-2025) & (K Unit)
Table 85. North America Prostacyclin Sales by Country (2026-2031) & (K Unit)
Table 86. North America Prostacyclin Revenue by Country (2020-2025) & (US$ Million)
Table 87. North America Prostacyclin Revenue by Country (2026-2031) & (US$ Million)
Table 88. North America Prostacyclin Sales by Type (2020-2025) & (K Unit)
Table 89. North America Prostacyclin Sales by Application (2020-2025) & (K Unit)
Table 90. Asia-Pacific Prostacyclin Sales by Region (2020-2025) & (K Unit)
Table 91. Asia-Pacific Prostacyclin Sales by Region (2026-2031) & (K Unit)
Table 92. Asia-Pacific Prostacyclin Revenue by Region (2020-2025) & (US$ Million)
Table 93. Asia-Pacific Prostacyclin Revenue by Region (2026-2031) & (US$ Million)
Table 94. Asia-Pacific Prostacyclin Sales by Type (2020-2025) & (K Unit)
Table 95. Asia-Pacific Prostacyclin Sales by Application (2020-2025) & (K Unit)
Table 96. Europe Prostacyclin Sales by Country (2020-2025) & (K Unit)
Table 97. Europe Prostacyclin Sales by Country (2026-2031) & (K Unit)
Table 98. Europe Prostacyclin Revenue by Country (2020-2025) & (US$ Million)
Table 99. Europe Prostacyclin Revenue by Country (2026-2031) & (US$ Million)
Table 100. Europe Prostacyclin Sales by Type (2020-2025) & (K Unit)
Table 101. Europe Prostacyclin Sales by Application (2020-2025) & (K Unit)
Table 102. Latin America Prostacyclin Sales by Country (2020-2025) & (K Unit)
Table 103. Latin America Prostacyclin Sales by Country (2026-2031) & (K Unit)
Table 104. Latin America Prostacyclin Revenue by Country (2020-2025) & (US$ Million)
Table 105. Latin America Prostacyclin Revenue by Country (2026-2031) & (US$ Million)
Table 106. Latin America Prostacyclin Sales by Type (2020-2025) & (K Unit)
Table 107. Latin America Prostacyclin Sales by Application (2020-2025) & (K Unit)
Table 108. Middle East and Africa Prostacyclin Sales by Country (2020-2025) & (K Unit)
Table 109. Middle East and Africa Prostacyclin Sales by Country (2026-2031) & (K Unit)
Table 110. Middle East and Africa Prostacyclin Revenue by Country (2020-2025) & (US$ Million)
Table 111. Middle East and Africa Prostacyclin Revenue by Country (2026-2031) & (US$ Million)
Table 112. Middle East and Africa Prostacyclin Sales by Type (2020-2025) & (K Unit)
Table 113. Middle East and Africa Prostacyclin Sales by Application (2020-2025) & (K Unit)
Table 114. Prostacyclin Key Raw Materials, Industry Status and Trend
Table 115. Prostacyclin Key Raw Materials and Upstream Suppliers
Table 116. Prostacyclin Clients Status and Trend
Table 117. Prostacyclin Typical Clients
Table 118. Prostacyclin Distributors
Table 119. Prostacyclin Market Trends
Table 120. Prostacyclin Market Drivers
Table 121. Prostacyclin Market Challenges
Table 122. Prostacyclin Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Prostacyclin Product Picture
Figure 2. Global Prostacyclin Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Prostacyclin Sales Market Share by Type in 2024 & 2031
Figure 4. Epoprostenol Sodium Product Picture
Figure 5. Treprostinil Product Picture
Figure 6. Iloprost Product Picture
Figure 7. Beraprost Sodium Product Picture
Figure 8. Global Prostacyclin Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Prostacyclin Sales Market Share by Application in 2024 & 2031
Figure 10. For Injection
Figure 11. For Oral
Figure 12. For Inhalation
Figure 13. Prostacyclin Report Years Considered
Figure 14. Global Prostacyclin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Prostacyclin Market Size 2020-2031 (US$ Million)
Figure 16. Global Prostacyclin Sales 2020-2031 (K Unit)
Figure 17. Global Prostacyclin Sales Market Share Forecast by Region (2020-2031)
Figure 18. Global Prostacyclin Revenue Market Share by Region (2020-2031)
Figure 19. Global Prostacyclin Sales Market Share Forecast by Type (2020-2031)
Figure 20. Global Prostacyclin Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Prostacyclin Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 22. Global Prostacyclin Sales Market Share Forecast by Application (2020-2031)
Figure 23. Global Prostacyclin Revenue Market Share Forecast by Application (2020-2031)
Figure 24. Prostacyclin Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 25. Epoprostenol Sodium of Prostacyclin Revenue Market Share by Application, 2024 VS 2031
Figure 26. Treprostinil of Prostacyclin Revenue Market Share by Application, 2024 VS 2031
Figure 27. Iloprost of Prostacyclin Revenue Market Share by Application, 2024 VS 2031
Figure 28. Beraprost Sodium of Prostacyclin Revenue Market Share by Application, 2024 VS 2031
Figure 29. Global Prostacyclin Sales Share by Manufacturer in 2024
Figure 30. Prostacyclin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Epoprostenol Sodium Market Sales Proportion by Manufacturer in 2024
Figure 32. Treprostinil Market Sales Proportion by Manufacturer in 2024
Figure 33. Iloprost Market Sales Proportion by Manufacturer in 2024
Figure 34. Beraprost Sodium Market Sales Proportion by Manufacturer in 2024
Figure 35. North America Prostacyclin Revenue 2020-2031 (US$ Million)
Figure 36. North America Prostacyclin Sales Market Share by Type (2020-2025)
Figure 37. North America Prostacyclin Sales Market Share by Application (2020-2025)
Figure 38. Asia-Pacific Prostacyclin Revenue 2020-2031 (US$ Million)
Figure 39. Asia-Pacific Prostacyclin Sales Market Share by Region (2020-2031)
Figure 40. Asia-Pacific Prostacyclin Revenue Market Share by Region (2020-2031)
Figure 41. Asia-Pacific Prostacyclin Sales Market Share by Type (2020-2025)
Figure 42. Asia-Pacific Prostacyclin Sales Market Share by Application (2020-2025)
Figure 43. Europe Prostacyclin Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Europe Prostacyclin Sales Market Share by Country (2020-2031)
Figure 45. Europe Prostacyclin Revenue Market Share by Country (2020-2031)
Figure 46. Europe Prostacyclin Sales Market Share by Type (2020-2025)
Figure 47. Europe Prostacyclin Sales Market Share by Application (2020-2025)
Figure 48. Latin America Prostacyclin Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Latin America Prostacyclin Sales Market Share by Country (2020-2031)
Figure 50. Latin America Prostacyclin Revenue Market Share by Country (2020-2025)
Figure 51. Latin America Prostacyclin Sales Market Share by Type (2020-2025)
Figure 52. Latin America Prostacyclin Sales Market Share by Application (2020-2025)
Figure 53. Middle East and Africa Prostacyclin Revenue Growth Rate 2020-2031 (US$ Million)
Figure 54. Middle East and Africa Prostacyclin Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Prostacyclin Revenue Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Prostacyclin Sales Market Share by Type (2020-2025)
Figure 57. Middle East and Africa Prostacyclin Sales Market Share by Application (2020-2025)
Figure 58. Prostacyclin Supply Chain (Upstream and Downstream Market)
Figure 59. Global Production Market Share of Prostacyclin Raw Materials by Region in 2024
Figure 60. Prostacyclin Distribution Channels
Figure 61. Global Prostacyclin Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 62. Global Prostacyclin Percentage 2020-2031: Online Sales VS Offline Sales
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Prostacyclin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Prostacyclin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Prostacyclin Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Prostacyclin Sales by Region (2020-2025) & (K Unit)
Table 5. Global Prostacyclin Sales Forecast by Region (2026-2031) & (K Unit)
Table 6. Global Prostacyclin Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Prostacyclin Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Prostacyclin Sales Volume by Type (2020-2025) & (K Unit)
Table 9. Global Prostacyclin Sales Volume by Type (2026-2031) & (K Unit)
Table 10. Global Prostacyclin Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Prostacyclin Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Prostacyclin Sales Volume by Application (2020-2025) & (K Unit)
Table 13. Global Prostacyclin Sales Volume by Application (2026-2031) & (K Unit)
Table 14. Global Prostacyclin Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Prostacyclin Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Prostacyclin Sales by Manufacturer (2020-2025) & (K Unit)
Table 17. Global Prostacyclin Sales Share by Manufacturer (2020-2025)
Table 18. Prostacyclin Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Prostacyclin Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Prostacyclin Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Prostacyclin Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Prostacyclin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Prostacyclin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostacyclin as of 2024)
Table 24. Prostacyclin Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Prostacyclin Market
Table 26. Manufacturers Prostacyclin Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. United Therapeutics Company Information
Table 29. United Therapeutics Description and Business Overview
Table 30. United Therapeutics Prostacyclin Product
Table 31. United Therapeutics Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. United Therapeutics Sales Proportion of Prostacyclin by Product in 2024
Table 33. United Therapeutics Sales Proportion of Prostacyclin by Application in 2024
Table 34. United Therapeutics Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 35. United Therapeutics Recent Developments
Table 36. Actelion (J & J) Company Information
Table 37. Actelion (J & J) Description and Business Overview
Table 38. Actelion (J & J) Prostacyclin Product
Table 39. Actelion (J & J) Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Actelion (J & J) Sales Proportion of Prostacyclin by Product in 2024
Table 41. Actelion (J & J) Sales Proportion of Prostacyclin by Application in 2024
Table 42. Actelion (J & J) Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 43. Actelion (J & J) Recent Developments
Table 44. GSK Company Information
Table 45. GSK Description and Business Overview
Table 46. GSK Prostacyclin Product
Table 47. GSK Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. GSK Sales Proportion of Prostacyclin by Product in 2024
Table 49. GSK Sales Proportion of Prostacyclin by Application in 2024
Table 50. GSK Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 51. GSK Recent Developments
Table 52. Teva Company Information
Table 53. Teva Description and Business Overview
Table 54. Teva Prostacyclin Product
Table 55. Teva Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Teva Sales Proportion of Prostacyclin by Product in 2024
Table 57. Teva Sales Proportion of Prostacyclin by Application in 2024
Table 58. Teva Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 59. Teva Recent Developments
Table 60. Toray Company Information
Table 61. Toray Description and Business Overview
Table 62. Toray Prostacyclin Product
Table 63. Toray Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Toray Sales Proportion of Prostacyclin by Product in 2024
Table 65. Toray Sales Proportion of Prostacyclin by Application in 2024
Table 66. Toray Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 67. Toray Recent Developments
Table 68. Tide Pharma Company Information
Table 69. Tide Pharma Description and Business Overview
Table 70. Tide Pharma Prostacyclin Product
Table 71. Tide Pharma Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Tide Pharma Sales Proportion of Prostacyclin by Product in 2024
Table 73. Tide Pharma Sales Proportion of Prostacyclin by Application in 2024
Table 74. Tide Pharma Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 75. Tide Pharma Recent Developments
Table 76. Bayer AG Company Information
Table 77. Bayer AG Description and Business Overview
Table 78. Bayer AG Prostacyclin Product
Table 79. Bayer AG Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Bayer AG Sales Proportion of Prostacyclin by Product in 2024
Table 81. Bayer AG Sales Proportion of Prostacyclin by Application in 2024
Table 82. Bayer AG Sales Proportion of Prostacyclin by Geographic Area in 2024
Table 83. Bayer AG Recent Developments
Table 84. North America Prostacyclin Sales by Country (2020-2025) & (K Unit)
Table 85. North America Prostacyclin Sales by Country (2026-2031) & (K Unit)
Table 86. North America Prostacyclin Revenue by Country (2020-2025) & (US$ Million)
Table 87. North America Prostacyclin Revenue by Country (2026-2031) & (US$ Million)
Table 88. North America Prostacyclin Sales by Type (2020-2025) & (K Unit)
Table 89. North America Prostacyclin Sales by Application (2020-2025) & (K Unit)
Table 90. Asia-Pacific Prostacyclin Sales by Region (2020-2025) & (K Unit)
Table 91. Asia-Pacific Prostacyclin Sales by Region (2026-2031) & (K Unit)
Table 92. Asia-Pacific Prostacyclin Revenue by Region (2020-2025) & (US$ Million)
Table 93. Asia-Pacific Prostacyclin Revenue by Region (2026-2031) & (US$ Million)
Table 94. Asia-Pacific Prostacyclin Sales by Type (2020-2025) & (K Unit)
Table 95. Asia-Pacific Prostacyclin Sales by Application (2020-2025) & (K Unit)
Table 96. Europe Prostacyclin Sales by Country (2020-2025) & (K Unit)
Table 97. Europe Prostacyclin Sales by Country (2026-2031) & (K Unit)
Table 98. Europe Prostacyclin Revenue by Country (2020-2025) & (US$ Million)
Table 99. Europe Prostacyclin Revenue by Country (2026-2031) & (US$ Million)
Table 100. Europe Prostacyclin Sales by Type (2020-2025) & (K Unit)
Table 101. Europe Prostacyclin Sales by Application (2020-2025) & (K Unit)
Table 102. Latin America Prostacyclin Sales by Country (2020-2025) & (K Unit)
Table 103. Latin America Prostacyclin Sales by Country (2026-2031) & (K Unit)
Table 104. Latin America Prostacyclin Revenue by Country (2020-2025) & (US$ Million)
Table 105. Latin America Prostacyclin Revenue by Country (2026-2031) & (US$ Million)
Table 106. Latin America Prostacyclin Sales by Type (2020-2025) & (K Unit)
Table 107. Latin America Prostacyclin Sales by Application (2020-2025) & (K Unit)
Table 108. Middle East and Africa Prostacyclin Sales by Country (2020-2025) & (K Unit)
Table 109. Middle East and Africa Prostacyclin Sales by Country (2026-2031) & (K Unit)
Table 110. Middle East and Africa Prostacyclin Revenue by Country (2020-2025) & (US$ Million)
Table 111. Middle East and Africa Prostacyclin Revenue by Country (2026-2031) & (US$ Million)
Table 112. Middle East and Africa Prostacyclin Sales by Type (2020-2025) & (K Unit)
Table 113. Middle East and Africa Prostacyclin Sales by Application (2020-2025) & (K Unit)
Table 114. Prostacyclin Key Raw Materials, Industry Status and Trend
Table 115. Prostacyclin Key Raw Materials and Upstream Suppliers
Table 116. Prostacyclin Clients Status and Trend
Table 117. Prostacyclin Typical Clients
Table 118. Prostacyclin Distributors
Table 119. Prostacyclin Market Trends
Table 120. Prostacyclin Market Drivers
Table 121. Prostacyclin Market Challenges
Table 122. Prostacyclin Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Prostacyclin Product Picture
Figure 2. Global Prostacyclin Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Prostacyclin Sales Market Share by Type in 2024 & 2031
Figure 4. Epoprostenol Sodium Product Picture
Figure 5. Treprostinil Product Picture
Figure 6. Iloprost Product Picture
Figure 7. Beraprost Sodium Product Picture
Figure 8. Global Prostacyclin Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Prostacyclin Sales Market Share by Application in 2024 & 2031
Figure 10. For Injection
Figure 11. For Oral
Figure 12. For Inhalation
Figure 13. Prostacyclin Report Years Considered
Figure 14. Global Prostacyclin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Prostacyclin Market Size 2020-2031 (US$ Million)
Figure 16. Global Prostacyclin Sales 2020-2031 (K Unit)
Figure 17. Global Prostacyclin Sales Market Share Forecast by Region (2020-2031)
Figure 18. Global Prostacyclin Revenue Market Share by Region (2020-2031)
Figure 19. Global Prostacyclin Sales Market Share Forecast by Type (2020-2031)
Figure 20. Global Prostacyclin Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Prostacyclin Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 22. Global Prostacyclin Sales Market Share Forecast by Application (2020-2031)
Figure 23. Global Prostacyclin Revenue Market Share Forecast by Application (2020-2031)
Figure 24. Prostacyclin Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 25. Epoprostenol Sodium of Prostacyclin Revenue Market Share by Application, 2024 VS 2031
Figure 26. Treprostinil of Prostacyclin Revenue Market Share by Application, 2024 VS 2031
Figure 27. Iloprost of Prostacyclin Revenue Market Share by Application, 2024 VS 2031
Figure 28. Beraprost Sodium of Prostacyclin Revenue Market Share by Application, 2024 VS 2031
Figure 29. Global Prostacyclin Sales Share by Manufacturer in 2024
Figure 30. Prostacyclin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Epoprostenol Sodium Market Sales Proportion by Manufacturer in 2024
Figure 32. Treprostinil Market Sales Proportion by Manufacturer in 2024
Figure 33. Iloprost Market Sales Proportion by Manufacturer in 2024
Figure 34. Beraprost Sodium Market Sales Proportion by Manufacturer in 2024
Figure 35. North America Prostacyclin Revenue 2020-2031 (US$ Million)
Figure 36. North America Prostacyclin Sales Market Share by Type (2020-2025)
Figure 37. North America Prostacyclin Sales Market Share by Application (2020-2025)
Figure 38. Asia-Pacific Prostacyclin Revenue 2020-2031 (US$ Million)
Figure 39. Asia-Pacific Prostacyclin Sales Market Share by Region (2020-2031)
Figure 40. Asia-Pacific Prostacyclin Revenue Market Share by Region (2020-2031)
Figure 41. Asia-Pacific Prostacyclin Sales Market Share by Type (2020-2025)
Figure 42. Asia-Pacific Prostacyclin Sales Market Share by Application (2020-2025)
Figure 43. Europe Prostacyclin Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Europe Prostacyclin Sales Market Share by Country (2020-2031)
Figure 45. Europe Prostacyclin Revenue Market Share by Country (2020-2031)
Figure 46. Europe Prostacyclin Sales Market Share by Type (2020-2025)
Figure 47. Europe Prostacyclin Sales Market Share by Application (2020-2025)
Figure 48. Latin America Prostacyclin Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Latin America Prostacyclin Sales Market Share by Country (2020-2031)
Figure 50. Latin America Prostacyclin Revenue Market Share by Country (2020-2025)
Figure 51. Latin America Prostacyclin Sales Market Share by Type (2020-2025)
Figure 52. Latin America Prostacyclin Sales Market Share by Application (2020-2025)
Figure 53. Middle East and Africa Prostacyclin Revenue Growth Rate 2020-2031 (US$ Million)
Figure 54. Middle East and Africa Prostacyclin Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Prostacyclin Revenue Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Prostacyclin Sales Market Share by Type (2020-2025)
Figure 57. Middle East and Africa Prostacyclin Sales Market Share by Application (2020-2025)
Figure 58. Prostacyclin Supply Chain (Upstream and Downstream Market)
Figure 59. Global Production Market Share of Prostacyclin Raw Materials by Region in 2024
Figure 60. Prostacyclin Distribution Channels
Figure 61. Global Prostacyclin Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 62. Global Prostacyclin Percentage 2020-2031: Online Sales VS Offline Sales
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232